Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
15 09 2020
Historique:
pubmed: 30 8 2020
medline: 27 10 2020
entrez: 30 8 2020
Statut: ppublish

Résumé

Currently there is an unmet need for treatments that can prevent hypertrophic cardiomyopathy (HCM). Using a murine model we previously identified that HCM causing cardiac troponin I mutation Gly203Ser (

Identifiants

pubmed: 32859761
pii: 2002976117
doi: 10.1073/pnas.2002976117
pmc: PMC7502707
doi:

Substances chimiques

Calcium Channels, L-Type 0
Peptides 0
Troponin I 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23113-23124

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Sci Rep. 2018 Aug 22;8(1):12538
pubmed: 30135446
J Am Heart Assoc. 2014 Jun 23;3(3):e000961
pubmed: 24958783
J Mol Cell Cardiol. 2009 Jun;46(6):1016-26
pubmed: 19166857
. 2013 Mar 15;304(6):H767-75
pubmed: 23335798
J Cell Biol. 1983 Jun;96(6):1736-42
pubmed: 6406518
Clin Exp Pharmacol Physiol. 2010 Feb;37(2):229-35
pubmed: 19671062
J Physiol. 2001 Dec 1;537(Pt 2):363-70
pubmed: 11731570
JACC Heart Fail. 2015 Feb;3(2):180-8
pubmed: 25543971
Mol Cell Biochem. 1998 Jul;184(1-2):101-5
pubmed: 9746315
Biochem J. 2000 Jun 15;348 Pt 3:657-65
pubmed: 10839999
Lancet. 2004 Jun 5;363(9424):1881-91
pubmed: 15183628
FASEB J. 2002 Aug;16(10):1205-16
pubmed: 12153988
PLoS One. 2016 Dec 14;11(12):e0168407
pubmed: 27973580
Cardiovasc Res. 2011 May 1;90(2):194-201
pubmed: 21502371
Cardiovasc Res. 2018 Aug 1;114(10):1273-1280
pubmed: 29912308
Circ Res. 2007 Apr 13;100(7):1036-44
pubmed: 17347474
J Mol Cell Cardiol. 2002 Oct;34(10):1259-71
pubmed: 12392982
J Physiol. 2016 Jul 15;594(14):4051-70
pubmed: 27062056
JACC Basic Transl Sci. 2018 Jun 25;3(3):391-402
pubmed: 30062225
Circulation. 2005 Nov 29;112(22):3451-61
pubmed: 16316967
Lancet. 2013 Jan 19;381(9862):242-55
pubmed: 22874472
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):E2905-14
pubmed: 24969422
PLoS One. 2015 Aug 12;10(8):e0134184
pubmed: 26267065
Trends Cardiovasc Med. 2002 Nov;12(8):339-48
pubmed: 12536120
Circ Res. 2013 Aug 30;113(6):709-24
pubmed: 23989714
J Proteome Res. 2010 Apr 5;9(4):1985-94
pubmed: 20131912
Science. 2016 Feb 5;351(6273):617-21
pubmed: 26912705
Am J Physiol. 1999 Dec;277(6):C1277-83
pubmed: 10600780
J Am Coll Cardiol. 2003 May 21;41(10):1776-82
pubmed: 12767664
Nature. 1994 Mar 3;368(6466):67-70
pubmed: 7509046
J Cell Mol Med. 2002 Apr-Jun;6(2):235-43
pubmed: 12169208
J Mol Cell Cardiol. 2003 Nov;35(11):1365-74
pubmed: 14596793
JACC Basic Transl Sci. 2016 Feb 13;1(1-2):61-72
pubmed: 30167506
J Proteome Res. 2013 Dec 6;12(12):5634-41
pubmed: 24164426
J Biol Chem. 2017 Oct 6;292(40):16571-16577
pubmed: 28808052
Cardiovasc Res. 2011 May 1;90(2):210-9
pubmed: 21398307
J Cell Biol. 2009 Mar 23;184(6):923-33
pubmed: 19307602
Prog Cardiovasc Dis. 2004 Nov-Dec;47(3):159-76
pubmed: 15736582
Methods Mol Biol. 2007;357:271-96
pubmed: 17172694
ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22085-22095
pubmed: 31150197
Clin Genet. 2018 Jan;93(1):3-14
pubmed: 28369730
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5251-7
pubmed: 7777493
. 2000 Feb;278(2):C423-35
pubmed: 10666039
Nature. 2004 Jun 10;429(6992):671-5
pubmed: 15141227
J Bioenerg Biomembr. 2003 Dec;35(6):599-620
pubmed: 15000522
Physiol Rev. 2010 Jan;90(1):207-58
pubmed: 20086077
Nat Genet. 1997 Aug;16(4):379-82
pubmed: 9241277
Circulation. 1995 Aug 15;92(4):785-9
pubmed: 7641357
J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660
pubmed: 32466879
J Mol Cell Cardiol. 2001 Apr;33(4):655-70
pubmed: 11273720
Front Physiol. 2014 Jun 03;5:209
pubmed: 24917826
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
J Mol Cell Cardiol. 2006 Oct;41(4):623-32
pubmed: 16950368
Arch Biochem Biophys. 2019 Apr 15;665:166-174
pubmed: 30885674
J Clin Invest. 2005 Dec;115(12):3306-17
pubmed: 16322774
Ann Intern Med. 2010 Apr 20;152(8):513-20, W181
pubmed: 20404382
Circulation. 2007 Apr 17;115(15):2033-41
pubmed: 17404155
Ann Intern Med. 2019 Jun 4;170(11):741-748
pubmed: 31035291
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1135-1145
pubmed: 29550319
Physiol Genomics. 2003 Jul 07;14(2):117-28
pubmed: 12759477
J Mol Cell Cardiol. 2011 Nov;51(5):740-8
pubmed: 21835182
Circulation. 2010 Jan 26;121(3):445-56
pubmed: 20100987
J Thorac Cardiovasc Surg. 2011 Dec;142(6):e153-203
pubmed: 22093723
Sci Transl Med. 2019 Jan 23;11(476):
pubmed: 30674652

Auteurs

Helena M Viola (HM)

School of Human Sciences (Physiology), The University of Western Australia, Crawley, WA 6009, Australia; helena.viola@uwa.edu.au livia.hool@uwa.edu.au.

Ashay A Shah (AA)

School of Human Sciences (Physiology), The University of Western Australia, Crawley, WA 6009, Australia.

Victoria P A Johnstone (VPA)

School of Human Sciences (Physiology), The University of Western Australia, Crawley, WA 6009, Australia.

Henrietta Cserne Szappanos (H)

School of Human Sciences (Physiology), The University of Western Australia, Crawley, WA 6009, Australia.

Mark P Hodson (MP)

Victor Chang Innovation Centre, Victor Chang Cardiac Research Institute, Sydney, NSW 2010, Australia.
School of Pharmacy, University of Queensland, Woolloongabba, QLD 4072, Australia.

Livia C Hool (LC)

School of Human Sciences (Physiology), The University of Western Australia, Crawley, WA 6009, Australia; helena.viola@uwa.edu.au livia.hool@uwa.edu.au.
Victor Chang Innovation Centre, Victor Chang Cardiac Research Institute, Sydney, NSW 2010, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH